A Prospective, Non-interventional Survey to Evaluate Injection Intervals and Treatment Modalities of Botulinum Toxin A (BoNT-A) in Adult Patients Suffering From Upper Limb Spasticity After Stroke (DECIDE)

Ipsen

Status: Terminated

Conditions: Upper Limb Spasticity After Stroke

Study type: Observational

Funder types: Industry

Identifiers

NCT01239628

A-48-52120-152

Details and patient eligibility

About

The purpose of the protocol is to evaluate injection intervals and treatment modalities up to 3 years follow-up of botulinum toxin A (BoNT-A) in adult patients suffering from upper limb spasticity after stroke.

Enrollment: 45 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject able to comply with the protocol
• Provision of written informed consent prior to collecting the data
• Male or female patients of 18 years or older
• Presenting with upper limb spasticity after stroke for which treatment with botulinum toxin A is indicated

Exclusion criteria

• The subject has already been included in this survey
• Patients who already received BoNT-A treatment for upper limb spasticity
• Patients with known intolerance for BoNT-A
• Subjects unable to comply with the protocol